{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:03:19Z","timestamp":1791864199178,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s10875-018-0584-x","type":"journal-article","created":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T10:02:23Z","timestamp":1548496943000},"page":"118-125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["TREX-1-Related Disease Associated with the Presence of Cryofibrinogenemia"],"prefix":"10.1007","volume":"39","author":[{"given":"C.","family":"Paradis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cadieux-Dion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Meloche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gravel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Paradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Des Roches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Leclerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cossette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9089-4604","authenticated-orcid":false,"given":"P.","family":"Begin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,26]]},"reference":[{"issue":"9","key":"584_CR1","first-page":"1445","volume":"56","author":"S Moiseev","year":"2017","unstructured":"Moiseev S, Luqmani R, Novikov P, Shevtsova T. Cryofibrinogenaemia-a neglected disease. Rheumatology (Oxford). 2017;56(9):1445\u201351.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"584_CR2","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.amjmed.2009.03.040","volume":"122","author":"D Saadoun","year":"2009","unstructured":"Saadoun D, Elalamy I, Ghillani-Dalbin P, Sene D, Delluc A, Cacoub P. Cryofibrinogenemia: new insights into clinical and pathogenic features. Am J Med. 2009;122(12):1128\u201335.","journal-title":"Am J Med"},{"key":"584_CR3","first-page":"203","volume":"61","author":"PA McKee","year":"1963","unstructured":"McKee PA, Kalbfleisch JM, Bird RM. Incidence and significance of cryofibrinogenemia. J Lab Clin Med J Lab Clin Med. 1963;61:203\u201310.","journal-title":"J Lab Clin Med J Lab Clin Med"},{"issue":"2","key":"584_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1046\/j.1365-2249.2000.01210.x","volume":"120","author":"H Blain","year":"2000","unstructured":"Blain H, Cacoub P, Musset L, Costedoat-Chalumeau N, Silberstein C, Chosidow O, et al. Cryofibrinogenaemia: a study of 49 patients. Clin Exp Immunol. 2000;120(2):253\u201360.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"584_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/rheumatology\/kem341","volume":"47","author":"CC Belizna","year":"2008","unstructured":"Belizna CC, Tron F, Joly P, Godin M, Hamidou M, L\u00e9vesque H. Outcome of essential cryofibrinogenaemia in a series of 61 patients. Rheumatology (Oxford). 2008;47(2):205\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"584_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1468-3083.1999.tb00808.x","volume":"12","author":"AJ Geest van","year":"1999","unstructured":"van Geest AJ, et al. Familial primary cryofibrinogenemia. J Eur Acad Dermatol Venereol. 1999;12(1):47\u201350.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"584_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/rheumatology\/35.1.102","volume":"35","author":"N Wulffraat","year":"1996","unstructured":"Wulffraat N, et al. Familial presence of primary cryofibrinogenaemia, a report of three cases. Br J Rheumatol. 1996;35(1):102\u20134.","journal-title":"Br J Rheumatol"},{"issue":"5","key":"584_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00109-007-0199-9","volume":"85","author":"MA Lee-Kirsch","year":"2007","unstructured":"Lee-Kirsch MA, Chowdhury D, Harvey S, Gong M, Senenko L, Engel K, et al. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J Mol Med (Berl). 2007;85(5):531\u20137.","journal-title":"J Mol Med (Berl)"},{"issue":"3","key":"584_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10875-015-0147-3","volume":"35","author":"GI Rice","year":"2015","unstructured":"Rice GI, Rodero MP, Crow YJ. Human disease phenotypes associated with mutations in TREX1. J Clin Immunol. 2015;35(3):235\u201343.","journal-title":"J Clin Immunol"},{"issue":"12","key":"584_CR10","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1038\/jid.2012.210","volume":"132","author":"K Sugiura","year":"2012","unstructured":"Sugiura K, Takeichi T, Kono M, Ito Y, Ogawa Y, Muro Y, et al. Severe chilblain lupus is associated with heterozygous missense mutations of catalytic amino acids or their adjacent mutations in the exonuclease domains of 3\u2032-repair exonuclease 1. J Invest Dermatol. 2012;132(12):2855\u20137.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"584_CR11","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1365-2133.2012.10813.x","volume":"167","author":"V Tungler","year":"2012","unstructured":"Tungler V, et al. Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutieres syndrome. Br J Dermatol. 2012;167(1):212\u20134.","journal-title":"Br J Dermatol"},{"issue":"2","key":"584_CR12","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/rheumatology\/kes181","volume":"52","author":"J Abe","year":"2013","unstructured":"Abe J, Izawa K, Nishikomori R, Awaya T, Kawai T, Yasumi T, et al. Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome\/familial chilblain lupus. Rheumatology (Oxford). 2013;52(2):406\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"584_CR13","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1016\/j.jaad.2013.04.020","volume":"69","author":"C Gunther","year":"2013","unstructured":"Gunther C, et al. Systemic involvement in TREX1-associated familial chilblain lupus. J Am Acad Dermatol. 2013;69(4):e179\u201381.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"584_CR14","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s00415-013-7084-y","volume":"260","author":"K Yamashiro","year":"2013","unstructured":"Yamashiro K, Tanaka R, Li Y, Mikasa M, Hattori N. A TREX1 mutation causing cerebral vasculopathy in a patient with familial chilblain lupus. J Neurol. 2013;260(10):2653\u20135.","journal-title":"J Neurol"},{"issue":"4","key":"584_CR15","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1001\/jamadermatol.2014.3438","volume":"151","author":"C Gunther","year":"2015","unstructured":"Gunther C, et al. Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3\u2032 repair exonuclease 1 (TREX1). JAMA Dermatol. 2015;151(4):426\u201331.","journal-title":"JAMA Dermatol"},{"issue":"12","key":"584_CR16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ejmg.2017.09.004","volume":"60","author":"RM Kisla Ekinci","year":"2017","unstructured":"Kisla Ekinci RM, Balci S, Bisgin A, Altintas DU, Yilmaz M. A homozygote TREX1 mutation in two siblings with different phenotypes: chilblains and cerebral vasculitis. Eur J Med Genet. 2017;60(12):690\u20134.","journal-title":"Eur J Med Genet"},{"issue":"10","key":"584_CR17","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/jmg.26.10.631","volume":"26","author":"Y Lolin","year":"1989","unstructured":"Lolin Y, Razis PA, O\u2019Gorman P, Hjelm M, Wierzbicki AS. Transient nephrotic syndrome after anaesthesia resulting from a familial cryofibrinogen precipitating at 35 degrees C. J Med Genet. 1989;26(10):631\u20136.","journal-title":"J Med Genet"},{"issue":"16","key":"584_CR18","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.1073\/pnas.1423804112","volume":"112","author":"JL Grieves","year":"2015","unstructured":"Grieves JL, Fye JM, Harvey S, Grayson JM, Hollis T, Perrino FW. Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease. Proc Natl Acad Sci U S A. 2015;112(16):5117\u201322.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"584_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/ni.2872","volume":"15","author":"HE Volkman","year":"2014","unstructured":"Volkman HE, Stetson DB. The enemy within: endogenous retroelements and autoimmune disease. Nat Immunol. 2014;15(5):415\u201322.","journal-title":"Nat Immunol"},{"issue":"14","key":"584_CR20","doi-asserted-by":"publisher","first-page":"10537","DOI":"10.1074\/jbc.M700039200","volume":"282","author":"U Silva de","year":"2007","unstructured":"de Silva U, Choudhury S, Bailey SL, Harvey S, Perrino FW, Hollis T. The crystal structure of TREX1 explains the 3\u2032 nucleotide specificity and reveals a polyproline II helix for protein partnering. J Biol Chem. 2007;282(14):10537\u201343.","journal-title":"J Biol Chem"},{"issue":"37","key":"584_CR21","doi-asserted-by":"publisher","first-page":"32373","DOI":"10.1074\/jbc.M111.276287","volume":"286","author":"JM Fye","year":"2011","unstructured":"Fye JM, Orebaugh CD, Coffin SR, Hollis T, Perrino FW. Dominant mutation of the TREX1 exonuclease gene in lupus and Aicardi-Goutieres syndrome. J Biol Chem. 2011;286(37):32373\u201382.","journal-title":"J Biol Chem"},{"issue":"1","key":"584_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/ana.410150109","volume":"15","author":"J Aicardi","year":"1984","unstructured":"Aicardi J, Goutieres F. A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol. 1984;15(1):49\u201354.","journal-title":"Ann Neurol"},{"issue":"10","key":"584_CR23","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1002\/ajmg.a.33620","volume":"152A","author":"CA Haaxma","year":"2010","unstructured":"Haaxma CA, Crow YJ, van Steensel MAM, Lammens MMY, Rice GI, Verbeek MM, et al. A de novo p.Asp18Asn mutation in TREX1 in a patient with Aicardi-Goutieres syndrome. Am J Med Genet A. 2010;152A(10):2612\u20137.","journal-title":"Am J Med Genet A"},{"issue":"10","key":"584_CR24","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s10067-008-0975-0","volume":"27","author":"CM Hedrich","year":"2008","unstructured":"Hedrich CM, Fiebig B, Hauck FH, Sallmann S, Hahn G, Pfeiffer C, et al. Chilblain lupus erythematosus-a review of literature. Clin Rheumatol. 2008;27(10):1341.","journal-title":"Clin Rheumatol"},{"issue":"8","key":"584_CR25","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1016\/S0021-9258(18)53402-5","volume":"268","author":"NW Toribara","year":"1993","unstructured":"Toribara NW, Roberton AM, Ho SB, Kuo WL, Gum E, Hicks JW, et al. Human gastric mucin. Identification of a unique species by expression cloning. J Biol Chem. 1993;268(8):5879\u201385.","journal-title":"J Biol Chem"},{"issue":"supp 1","key":"584_CR26","doi-asserted-by":"publisher","first-page":"O85","DOI":"10.1186\/1546-0096-13-S1-O85","volume":"13","author":"F Kara Eroglu","year":"2015","unstructured":"Kara Eroglu F, et al. STING-associated vasculopathy with onset in infancy: new clinical findings and mutation in three Turkish children. Pediatr Rheumatol Online J. 2015;13(supp 1):O85.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"3","key":"584_CR27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/RHU.0b013e318289e06e","volume":"19","author":"M Michaud","year":"2013","unstructured":"Michaud M, Pourrat J. Cryofibrinogenemia. J Clin Rheumatol. 2013;19(3):142\u20138.","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"584_CR28","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/hmg\/ddv454","volume":"25","author":"PS Vries de","year":"2016","unstructured":"de Vries PS, Chasman DI, Sabater-Lleal M, Chen MH, Huffman JE, Steri M, et al. A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration. Hum Mol Genet. 2016;25(2):358\u201370.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"584_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1600-0625.2008.00723.x","volume":"17","author":"N Dang","year":"2008","unstructured":"Dang N, Murrell DF. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa. Exp Dermatol. 2008;17(7):553\u201368.","journal-title":"Exp Dermatol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-018-0584-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-018-0584-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-018-0584-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T00:23:12Z","timestamp":1662855792000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-018-0584-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["584"],"URL":"https:\/\/doi.org\/10.1007\/s10875-018-0584-x","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"28 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This project was approved by the research ethics committee of the Centre Hospitalier de l\u2019Universit\u00e9 de Montreal. The participants received no financial compensation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}